-+ 0.00%
-+ 0.00%
-+ 0.00%

MEDICINOVA ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN COMBAT-ALS PHASE 2B/3 CLINICAL TRIAL OF MN-166 (IBUDILAST)

Reuters·09/22/2025 12:00:00

Please log in to view news